Xuke Chen Selected Research

Infections

1/2020

Deubiquitinase Inhibitor b-AP15 Attenuated LPS-Induced Inflammation via Inhibiting ERK1/2, JNK, and NF-Kappa B.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xuke Chen Research Topics

Disease

3	Atherosclerosis 01/2020 - 01/2020
2	Fibrosis (Cirrhosis) 01/2021 - 01/2021
2	Inflammation (Inflammations) 01/2020 - 11/2019
1	Hypertrophy 01/2021
1	Infections 01/2020
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020
1	Neoplasms (Cancer) 01/2020
1	Infarction (Infarctions) 11/2019
1	Myocardial Infarction 11/2019

Drug/Important Bio-Agent (IBA)

2	Deubiquitinating EnzymesIBA 01/2020 - 01/2020
1	salicylhydroxamic acid (SHAM)IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	UbiquitinIBA 01/2021
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2021
1	Ubiquitin-Specific ProteasesIBA 01/2021
1	LipidsIBA 01/2020
1	CD36 AntigensIBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	oxidized low density lipoproteinIBA 01/2020
1	Lipoproteins (Lipoprotein)IBA 01/2020
1	SaponinsIBA 01/2020
1	NF-kappa B (NF-kB)IBA 01/2020
1	LipopolysaccharidesIBA 11/2019
1	Therapeutic UsesIBA 11/2019

Therapy/Procedure

1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2020
1	Therapeutics 11/2019